Tissue maturation correlating to clinical manifestations in juvenile angiofibroma

Annals of Otology, Rhinology and Laryngology

Volumn 114, Issue 9, 2005, Pages 705-708

  Sennes, Luiz U ^a,b   Fortes, Felipe S G ^a   Butugan, Ossamu ^a   Saldiva, Paulo H ^a   Bernardi, Fabiola C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical manifestation; Histology; Juvenile nasopharyngeal angiofibroma; Maturation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BENIGN TUMOR; BLOOD VESSEL; CELL MATURATION; CELL TYPE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; EPISTAXIS; FACE MALFORMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; MUSCLE CELL; NASOPHARYNX FIBROMA; NOSE OBSTRUCTION; PHARYNX TUMOR; PRIORITY JOURNAL; RARE DISEASE; STATISTICAL SIGNIFICANCE;

EID: 25144523894     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940511400909     Document Type: Article

References (17)

1. Martin H, Ehrlich HE, Abels JC. Juvenile nasopharyngeal angiofibroma. Ann Surg 1948;127:513-36.
2. Lloyd G, Howard D, Phelps P, Cheesman A. Juvenile angiofibroma: the lessons of 20 years of modern imaging. J Laryngol Otol 1999;113:127-34.
3. Sennes LU, Butugan O, Sanchez TG, Bento RF, Tsuji DH. Juvenile nasopharyngeal angiofibroma: the routes of invasion. Rhinology 2003;41:235-40.
4. Brentani MM, Butugan O, Oshima CTF, Torloni H, Paiva LJ. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 1989;99:398-401.
5. Schiff M, Gonzalez AM, Ong M, Baird A. Juvenile nasopharyngeal angiofibroma contains an angiogenic growth factor: basic FGF. Laryngoscope 1992;102:940-5.
6. Nagai MA, Butugan O, Logullo A, Brentani MM. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope 1996;106:190-5.
7. Kumagami H. Estradiol, dihydrotestosterone and testosterone in juvenile nasopharyngeal angiofibroma tissue. Am J Rhinol 1993;7:101-4.
8. Stansbie JM, Phelps PD. Involution of residual juvenile nasopharyngeal angiofibroma (a case report). J Laryngol Otol 1986;100:599-603.
9. Weprin LS, Siemers PT. Spontaneous regression of juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 1991;117:796-9.
10. Harrison DFN. The natural history, pathogenesis, and treatment of juvenile angiofibroma. Personal experience with 44 patients. Arch Otolaryngol Head Neck Surg 1987;113:936-42.
11. Schiff M. Juvenile nasopharyngeal angiofibroma. A theory of pathogenesis. Laryngoscope 1959;69:981-1016.
12. Sennes LU, Butugan O, Sanchez TG, Bernardi FDC, Saldiva PHN. Tissue maturation during the growth of juvenile nasopharyngeal angiofibroma. Ann Otol Rhinol Laryngol 2004; 113:34-8.
13. Beham A, Beham-Schmid C, Regauer S, Aubock L, Stammberger H. Nasopharyngeal angiofibroma: true neoplasm or vascular malformation? Adv Anat Pathol 2000;7:36-46.
14. Coutinho-Camillo CM, Brentani MM, Butugan O, Torloni H, Nagai MA. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas. Diagn Mol Pathol 2003; 12:57-62.
15. Wang HW, Su WY, Wang JY. Noradrenergic innervation of juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 1994;251:123-6.
16. Liang J, Yi Z, Lianq P. The nature of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 2000;123:475-81.
17. Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT. Angiofibroma. Changes in staging and treatment. Arch Otolaryngol Head Neck Surg 1996;122:122-9.